Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Observational × Hyperandrogenism × Clear all

Status

Completed 8 Unknown 2 Terminated 2 Suspended 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 14 Neoplasms 9 Colorectal Neoplasms 6 Prostatic Neoplasms 4 Glioblastoma 3 Diabetes Mellitus 3 Crohn Disease 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Testicular Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Polycystic Ovary Syndrome 2 Ovarian Neoplasms 2 Non-alcoholic Fatty Liver Disease 2 Multiple Sclerosis 2 Lung Neoplasms 2 Irritable Bowel Syndrome 2 Endometrial Neoplasms 2 Dyslipidemias 2 Colonic Neoplasms 2 Colitis, Ulcerative 2 Celiac Disease 2 Carcinoma, Renal Cell 2 Arthritis, Rheumatoid 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Spinal Diseases 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02611128 2023-11-02

DENND1A

University of Virginia

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡